Intestinal postprandial chylomicrons: state of the union between liver, gut and dyslipidemia?

Bibliography

• Zilversmit DB: Atherogenesis:a postprandial phenomenon. Circulation 60,473–485 (1979).
   Google Scholar
• Hui DY, Labonte ED, Howles PN:Development and physiological regulationof intestinal lipid absorption. III.Intestinal transporters and cholesterolabsorption. Am. J. Physiol. Gastrointest.Liver Physiol. 294(4), G839–G843(2008).
   Google Scholar
• Adeli K, Lewis GF: Intestinal lipoproteinoverproduction in insulin-resistant states.Curr. Opin. Lipidol. 19(3), 221–228(2008).
   Google Scholar
• Review of in vitro, animal and humanstudies on CM/apoB48 productionand potential mechanisms in insulinresistance (IR).
   Google Scholar
• Mamo JCL, Proctor SD: Chylomicronremnants and atherosclerosis. In: PlasmaLipids and Their Role in Disease. Barter PJ,Rye K-A (Eds). Harwood AcademicPublishers, NJ, USA 6, 109–137 (1999).
   Google Scholar
• Karpe F, Steiner G, Uffelman K,Olivecrona T, Hamsten A: Postprandiallipoproteins and progression of coronaryatherosclerosis. Atherosclerosis 106(1), 83–97(1994).
   Google Scholar
• Proctor SD, Vine DF, Mamo JC:Arterial permeability and efflux ofapolipoprotein B-containing lipoproteinsassessed by in situ perfusion and threedimensionalquantitative confocalmicroscopy. Arterioscler. Thromb. Vasc. Biol.24(11), 2162–2167 (2004).
   Google Scholar
• Evidence of arterial retention and efflux ofchylomicron remnants (CMr) particles.
   Google Scholar
• Proctor SD, Mamo JC: Intimal retention ofcholesterol derived from apolipoproteinB100- and apolipoprotein B48-containinglipoproteins in carotid arteries of Watanabeheritable hyperlipidemic rabbits. Arterioscler.Thromb. Vasc. Biol. 23(9), 1595–1600(2003).
   Google Scholar
• Proctor SD, Mamo JCL: Retention offluorescent labelled chylomicronremnantswithin the intima of the arterialwall – evidence that plaque cholesterolmay be derived from postprandiallipoproteins. Eur. J. Clin. Invest. 28(6),497–503 (1998).
   Google Scholar
• Proctor SD, Mamo JCL: Arterialretention of apolipoprotein B48 andB100-containing lipoproteins inatherogenesis. Curr. Opin. Lipidol. 13,461–470 (2002).
   Google Scholar
• Van Oostrom AJ, Van Wijk JPH,Castro Cabezas M: Lipaemia, inflammationand atherosclerosis: novel opportunities inthe understanding and treatment ofatherosclerosis. Drugs 64(Suppl. 2), 19–41(2004).
   Google Scholar
• Alipour A, Elte JWF, van Zaanen HCT,Rietveld AP, Castro Cabezas M: Postprandialinflammation and endothelial dysfunction.Biochem. Soc. Trans. 35, 466–469 (2007).
   Google Scholar
• Kruit JK, Groen AK, van Berkel TJ,Kuipers F: Emerging roles of the intestine incontrol of cholesterol metabolism. World J.Gastroenterol. 12(40), 6429–6439 (2006).
   Google Scholar
• Lally S, Owens D, Tomkin GH: Genes thataffect cholesterol synthesis, cholesterolabsorption, and chylomicron assembly: therelationship between the liver and intestinein control and streptozotosin diabetic rats.Metabolism 56(3), 430–438 (2007).
   Google Scholar
• Pivotal studies in examining interrelationshipbetween intestine and liver inlipoprotein and cholesterol metabolism.
   Google Scholar
• Lewis GF, Naples M, Uffelman K, Leung N,Szeto L, Adeli K: Intestinal lipoproteinproduction is stimulated by an acuteelevation of plasma free fatty acids in thefasting states. Endocrinology 145,5006–5012 (2004).
   Google Scholar
• Bonen A, Chabowski A, Luiken JJ, Glatz JF:Is membrane transport of FFA mediated bylipid, protein, or both? Mechanisms andregulation of protein-mediated cellular fattyacid uptake: molecular, biochemical andphysiological evidence. Physiology (Bethesda)22, 15–29 (2007).
   Google Scholar
• Davis H, Basso F, Hoos LM, Tetzloff G, LallySM, Altmann SW: Cholesterol homeostasis bythe intestine: lessons from Niemann–Pick C1like 1 (NPC1L1). Athero. Suppl. DOI:10.1016/j.atheroclerosissup.2008.05.008(2008) (Epub ahead of print).
   Google Scholar
• Key findings of Niemann–Pick C1-like(NPC1L)1 null mice resistant todiet-induced hypercholetesrolemiaand NPC1L1/apoE null mice showno atherosclerosis and relationship toCMr is examined.
   Google Scholar
• Tomkin GH: The intestine as a regulator ofcholesterol homeostasis in diabetes. Athero.Suppl. (2008) (Epub ahead of print).
   Google Scholar
• Vine DF, Glimm DR, Proctor SD: Intestinallipid transport and chylomicron production:possible links to exacerbated atherogenesisin a rodent model of the metabolicsyndrome. Athero. Suppl. DOI:10.1016/j.atherosclerosissup.2008.05.004(2008) (Epub ahead of print).
   Google Scholar
• Direct evidence of intestinal CMoverproduction in rodent model of IR.
   Google Scholar
• Drover VA, Ajmal M, Nassir F et al.: CD36deficiency impairs lipid clearance andclearance of chylomicrons from the blood.J. Clin. Invest. 115, 1290–1297 (2005).
   Google Scholar
• Nassir F, Wilson B, Han X, Gross RW,Abumrad NA: CD36 is importantfor fatty acid and cholesterol uptakeby the proximal but not distal intestine.J. Biol. Chem. 282(27), 19493–19501(2007).
   Google Scholar
• Nauli AM, Nassir F, Zheng S et al.:CD36 is important for chylomicronformation and secretion and may mediatecholesterol uptake in the proximal intestine.Gastroenterology 131(4), 1197–1207(2006).
   Google Scholar
• Norata GD, Grigore L, Raselli Set al.: Postprandial endothelialdysfunction in hypertriglyceridemicsubjects: molecular mechanisms and geneexpression studies. Atherosclerosis 193,321–327 (2007).
   Google Scholar
• Direct evidence of exacerbated molecularresponse in vascular inflammatory markersin postprandial lipemia phase.
   Google Scholar
• Van Oostrom JH, Alipour A, Plokker TWM,Sniderman AD, Castro Cabezas M: Themetabolic syndrome in relation tocomplement component 3 and postprandiallipemia in patients from an outpatient lipidclinic and healthy volunteers. Atherosclerosis190, 167–173 (2007).
   Google Scholar
• Yang Y, Lu HL, Zhang J et al.:Relationships among acylationstimulating protein, adiponectin andcomplement C3 in lean vs obese Type 2diabetes. Int. J. Obes. (Lond.) 30(3),439–446 (2006).
   Google Scholar
• Cianflone K, Xia Z, Chen LY: Criticalreview of acylation-stimulating proteinphysiology in humans and rodents. Biochim.Biophys. Acta 1609, 127–143 (2003).
   Google Scholar
• Cianflone K, Paglialunga S, Roy C:Intestinally-dervived lipds: Metabolicregulation and consequences – an overview.Athero. Suppl. DOI:10.1016/j.athersclerosissup.2008.05.014(2008) (Epub ahead of print).
   Google Scholar
• Ross R: Atherosclerosis – an inflammatorydisease. N. Engl. J. Med. 340, 115–126 (1999).
   Google Scholar
• Van Oostrom AJ, Sijmonsma TP, Verseyden Cet al.: Postprandial recruitment of neutrophilsmay contribute to endothelial dysfunction.J. Lipid Res. 44, 576–583 (2003).
   Google Scholar
• Van Oostrom AJ, Plokker HWM,van Asbeck BS et al.: Effects of rosuvastatinon postprandial leukocytes in mildlyhyperlipidemic patients with prematurecoronary sclerosis. Atherosclerosis 185,331–339 (2006).
   Google Scholar
• Tertov VV, Kalenich OS, Orekhov AN:Lipid-laden white blood cells in thecirculation of patients with coronary heartdisease. Exp. Mol. Pathol. 57, 22–28 (1992).
   Google Scholar
• Alipour A, van Oostrom AJ, Izraeljan Aet al.: Leukocyte activation by triglyceriderichlipoproteins. Arterioscler. Thromb. Vasc.Biol. 28(4), 792–797 (2008).
   Google Scholar
• Review of postprandial triglyceride (TG)lipemia and inflammatory response anddiscussion of current clinical implications.
   Google Scholar
• Verseyden C, Meijssen S, Castro Cabezas M:Effects of atorvastatin on fasting plasma andmarginated apolipoproteins B48 and B100in large, triglyceride-rich lipoproteins infamilial combined hyperlipidemia. J. Clin.Endocrinol. Metab. 89, 5021–5029 (2004).
   Google Scholar
• Kadar A, Glasz T: Development ofatherosclerosis and plaque biology.Cardiovasc. Surgery 9, 109–121 (2001).
   Google Scholar
• Davignon J, Ganz P: Role of endothelialdyfunction in atherosclerosis. Circulation109(Suppl. III), III27–III32 (2004).
   Google Scholar
• Albertini R, Moratti R, DeLuca G: Oxidationof low-density lipoprotein in atherosclerosisfrom basic biochemistry to clinical studies.Curr. Mol. Med. 2, 579–592 (2002).
   Google Scholar
• Botham KM, Bravo E, Elliott J,Wheeler-Jones CPD: Direct interaction ofdietary lipids carried in chylomicron remnantswith cells of the artery wall: implications foratherosclerosis development. Curr.Pharmaceut. Design 11, 3681–3695 (2005).
   Google Scholar
• Cohn JS: Oxidized fat in the diet, postprandiallipaemia and cardiovascular disease. Curr.Opin. Lipidol. 13, 19–24 (2002).
   Google Scholar
• Yu KC, Mamo JCL: Chylomicronremnant-induced foam cell formationand cytotoxicity: a possible mechanismfor cell death in atherosclerosis. Clin. Sci. 98,183–192 (2000).
   Google Scholar
• Napolitano M, Rivabene R, Avella M,Botham KM, Bravo E: The internal redoxbalance of the cells influences the metabolismof lipids of dietary origin by J774macrophages: implications for foam cellformation. J. Vasc. Res. 38, 350–360 (2001).
   Google Scholar
• Batt KV, Avella M, Moore EH, Jackson B,Suckling KE, Botham KM: Differential effectsof low density lipoprotein and chylomicronremnants on lipid accumulation in humanmacrophages. Exp. Biol. Med. 229, 528–537(2004).
   Google Scholar
• Studies demonstrating nativeCMr induce lipid TG rather thancholesterol accumulation compared withoxidized LDL.
   Google Scholar
• Bejta F, Moore EH, Avella M,Gough PJ, Suckling KE, Botham KM:Oxidation of chylomicron remnant-likeparticles inhibits their uptake by THP-1macrophages by apolipoprotein Edependent processes. Biochim. Biophys. Acta1771, 901–910 (2007).
   Google Scholar
• Clarke R, Armitage J: Antioxidant vitaminsand risk of cardiovascular disease. Review oflarge scale randomised trials. Cardiovasc.Drugs Ther. 16, 411–441 (2002).
   Google Scholar
• Galloway S, Jian L, Chew S, Mamo JCL: -amyloid or its precursor protein isfound in epithelial cells of the smallintestine and is stimulated by high fatfeeding. J. Nutr. Biochem. 18, 279–284(2007).
   Google Scholar
• Evidence of intestinal amyloid metabolism linked to dietary fat intake.
   Google Scholar
• Kalmijn S, Launer LJ, Ott A et al.: Dietary fatintake and the risk of incident dementia in theRotterdam Study. Ann. Rev. 42, 776–782(1997).
   Google Scholar
• Petot GJ, Friedland RP: Lipids, diet and Alzheimer's disease: an extended summary.J. Neurol. Sci. 226, 31–33 (2004).
   Google Scholar
• Sparks DL, Scheff SW, Hunsacker JC 3rdet al.: Induction of Alzheimer-like -amyloid immunoreactivity in thebrains of rabbits with dietary cholesterol.Exp. Neurol. 126, 88–94 (1994).
   Google Scholar
• Refolo LM, Malester B, LaFrancois J et al.:Hypercholesterolemia accelerates the Alzheimer's-like pathology in a transgenicmouse model. Neurobiol. Dis. 4, 321–331(2000).
   Google Scholar
• Shie FS, Jin LW, Cook DG et al.: Dietinducedhypercholesterolemia enhancesbrain A accumulation in transgenic mice.Neuroreport 13, 455–459 (2002).
   Google Scholar
• Levin-Allerhand JA, Lominska CE,Smith JD: Increased amyloid levels inAPPSWE transgenic mice treatedchronically with a physiological high-fatcholesterol diet. J. Nutr. Health Ageing 6,315–319 (2002).
   Google Scholar
• George AJ, Holsinger RM, McClean CAet al.: APP intracellular domain is increasedand soluble A is reduced with diet-inducedhypercholesterolemia in a transgenic mousemodel of Alzheimer's disease. Neurobiol. Dis.16, 124–132 (2004).
   Google Scholar
• Boyt AA, Taddei K, Hallmayer Jet al.: Relationship between lipidmetabolism and plasma concentration ofamyloid precursor protein andapolipoprotein E. Alzheimers Reports 2,339–346 (1999).
   Google Scholar
• James AP, Pal S, Gennat HC, Vine DF,Mamo JC: The incorporation andmetabolism of amyloid- into chylomicronlikelipid emulsions. J. Alzheimers Dis. 5,179–188 (2003).
   Google Scholar
• James AP, Mamo JC: The immunodetectionof lipoprotein bound amyloid- isattenuated because of the presence of lipids.Ann. Clin. Biochem. 42, 70–72 (2005).
   Google Scholar
• Takechi R, Galloway S,Pallebage-Gamarallage MMS, Mamo JCL: Chylomicron amyloid- in the aetiology ofAlzheimer's disease. Athero. Suppl. DOI:10.1016/j.atherosclerosissup.2008.05.010 (2008) (Epub ahead of print).
   Google Scholar
• Tomkin GH, Owens D: Abnormalities inapoB-containing lipoproteins in diabetesand atherosclerosis. Diabetes Metab. Res. Rev.17, 27–43 (2001).
   Google Scholar
• Kolovou GD, Anagnostopoulou KK,Daskalopoulou SS et al.: Clinicalrelevance of postprandial lipaemia.Curr. Med. Chem. 12, 1931–1945 (2005).
   Google Scholar
• Lorec A, Juhel C, Parfumi Y et al.:Determination of apolipoproteinB-48 in plasma by competitive ELISA.Clin. Chem. 46, 1638–1642 (2000).
   Google Scholar
• Lovegrove J, Isherwood SG, Jackson KG,Williams CM, Gould BJ: Quantification ofapolipoprotein B-48 in triacylglycerol-richlipoproteins by a specific enzyme-linkedimmunosorbent assay. Biochem. Biophys.Acta 1301, 221–229 (1996).
   Google Scholar
• Van Oostrom AJ, Castro Cabezas M,Ribalta J et al.: Diurnal triglyceride profilesin healthy normolipidemic male subjects areassociated to insulin sensitivity, bodycomposition and diet. Eur. J. Clin. Invest.30, 964–971 (2000).
   Google Scholar
• Castro Cabezas M, Halkes CJM, Meijssen S,van Oostrom AJHHM, Erkelens DW:Diurnal triglyceride profiles: a novelapproach to study triglyceride changes.Atherosclerosis 155, 219–228 (2001).
   Google Scholar
• Van Wijk JPH, Halkes CJM, Erkelens DW,Castro Cabezas M: Fasting and daytimetriglycerides in obesity with and without Type2 diabetes. Metabolism 52, 1043–1049 (2003).
   Google Scholar
• Halkes CJM, Castro Cabezas M,van Wijk JPH, Erkelens DW: Genderdifferences in diurnal triglyceridemia in leanand overweight subjects. Int. J. Obes. 25,1767–1774 (2001).
   Google Scholar
• Van Wijk JPH, Castro Cabezas M,Halkes CJM, Erkelens DW: Effects ofdifferent nutrient intakes on daytimetriacylglycerolemia in healthy,normolipemic, free-living men. Am. J. Clin.Nutr. 74, 171–178 (2001).
   Google Scholar
• Delawi D, Meijssen S, Castro Cabezas M:Intra-individual variations of fasting plasmalipids, apolipoproteins and postprandiallipemia in familial combined hyperlipidemiacompared to controls. Clin. Chim. Acta. 328,139–145 (2003).
   Google Scholar